Anti-CTLA-4 human scFv antibodies prevent T-cell activation in transplantation.
Immunogenetics Laboratory, National Cancer Research Institute and Department of Oncology, Biology, and Genetics, c/o CBA, Genova, Italy.
M P
MP
Pistillo
P L
PL
Tazzari
F
F
Stirpe
A
A
Bolognesi
L
L
Polito
P
P
Capanni
C
C
Pioli
L
L
Gatta
V
V
Ubaldi
G
G
Doria
R
R
Conte
G B
GB
Ferrara
D000069594:Abatacept; D000906:Antibodies / Q000276:immunology*; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000276:immunology*; D060908:CTLA-4 Antigen; D006801:Humans; D018796:Immunoconjugates; D007135:Immunoglobulin Variable Region / Q000276:immunology*; D000922:Immunotoxins / Q000627:therapeutic use*; D008213:Lymphocyte Activation / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D000906:Antibodies; D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018796:Immunoconjugates; D007135:Immunoglobulin Variable Region; D000922:Immunotoxins; D000069594:Abatacept